Clinical Trial Update: To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating glibenclamide for reducing brain edema in traumatic brain injury (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: UNKNOWN